au.\*:("TINEL M")
Results 1 to 25 of 25
Selection :
FORMATION OF INACTIVE CYTOCHROME P-450 FE(II)-METABOLITE COMPLEXES WITH SEVERAL ERYTHROMYCIN DERIVATIVES BUT NOT WITH JOSAMYCIN AND MIDECAMYCIN IN RATSLARREY D; TINEL M; PESSAYRE D et al.1983; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1983; VOL. 32; NO 9; PP. 1487-1493; BIBL. 27 REF.Article
Methoxsalen decreases the metabolic activation and prevents the hepatotoxicity and nephrotoxicity of chloroform in micaLETTERON, P; DEGOTT, C; LABBE, G et al.Toxicology and applied pharmacology. 1987, Vol 91, Num 2, pp 266-273, issn 0041-008XArticle
Inhibition of rat liver estrogen 2/4-hydroxylase activity by troleandomycin : comparison with erythromycin and roxithromycinFISHER, D; LABBE, G; BERSON, A et al.The Journal of pharmacology and experimental therapeutics. 1990, Vol 254, Num 3, pp 1120-1127, issn 0022-3565, 8 p.Article
Metabolic activation of the new tricyclic antidepressant tianeptine by huam liver cytochrome P450LARREY, D; TINEL, M; LETTERON, P et al.Biochemical pharmacology. 1990, Vol 40, Num 3, pp 545-550, issn 0006-2952, 6 p.Article
Inhibitory effects of nilutamide, a new androgen receptor antagonist, on mouse and human liver cytochrome P-450BABANY, G; TINEL, M; LETTERON, P et al.Biochemical pharmacology. 1989, Vol 38, Num 6, pp 941-947, issn 0006-2952Article
Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in miceLETTERON, P; DESCATOIRE, V; LARREY, D et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 239, Num 2, pp 559-567, issn 0022-3565Article
Mechanism for isaxonine hepatitis. II: Protective role of glutathione and toxicological studies in miceFOUIN-FORTUNET, H; LETTERON, P; TINEL, M et al.The Journal of pharmacology and experimental therapeutics. 1984, Vol 229, Num 3, pp 851-858, issn 0022-3565Article
Polymorphism of dextromethorphan oxidation in a French populationLARREY, D; AMOUYAL, G; TINEL, M et al.British journal of clinical pharmacology. 1987, Vol 24, Num 5, pp 676-679, issn 0306-5251Article
Inactivation and induction of cytochrome P-450 by various psoralen derivatives in ratsLETTERON, P; DESCATOIRE, V; LARREY, D et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 238, Num 2, pp 685-692, issn 0022-3565Article
Protective effect of 16,16-dimethyl prostaglandin E2 on the hepatotoxicity of bromobenzene in miceFUNCK-BRENTANO, C; TINEL, M; DEGOTT, C et al.Biochemical pharmacology. 1984, Vol 33, Num 1, pp 89-96, issn 0006-2952Article
Effects of pregnancy on the toxicity and metabolism of acetaminophen in miceLARREY, D; LETTERON, P; FOLIOT, A et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 237, Num 1, pp 283-291, issn 0022-3565Article
Administration of high doses of human recombinant interleukin-2 decreases the expression of several cytochromes P-450 in the ratTHAL, C; KAHWAJI, J. E; LOEPER, J et al.The Journal of pharmacology and experimental therapeutics. 1994, Vol 268, Num 1, pp 515-521, issn 0022-3565Article
Metabolic activation of the antidepressant tianeptine. I: Cytochrome P-450-mediated in vitro covalent bindingLETTERON, P; DESCATOIRE, V; TINEL, M et al.Biochemical pharmacology. 1989, Vol 38, Num 19, pp 3241-3246, issn 0006-2952Article
Metabolic activation of the tricyclic antidepressant amineptine. II: Protective role of glutathione against in vitro and in vivo covalent bindingGENEVE, J; DEGOTT, C; LETTERON, P et al.Biochemical pharmacology. 1987, Vol 36, Num 3, pp 331-337, issn 0006-2952Article
What changes drug metabolism in critically ill patients ? Two preliminary studies in isolated human hepatocytesPARK, G. R; PICHARD, L; TINEL, M et al.Anaesthesia. 1994, Vol 49, Num 3, pp 188-191, issn 0003-2409Article
Pharmacogenetics of human erythrocyte thiopurine methyltransferase activity in a French populationTINEL, M; BERSON, A; PESSAYRE, D et al.British journal of clinical pharmacology. 1991, Vol 32, Num 6, pp 729-734, issn 0306-5251Article
Metabolic activation of the antidepressant tianeptine. II: In vivo covalent binding and toxicological studies at sublethal dosesLETTERON, P; LABBE, G; DESCATOIRE, V et al.Biochemical pharmacology. 1989, Vol 38, Num 19, pp 3247-3251, issn 0006-2952Article
Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivativesTINEL, M; BELGHITI, J; DESCATOIRE, V et al.Biochemical pharmacology. 1987, Vol 36, Num 6, pp 951-955, issn 0006-2952Article
Inactivation of cytochrome P-450 by the drug methoxsalenFOUIN-FORTUNET, H; TINEL, M; DESCATOIRE, V et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 236, Num 1, pp 237-247, issn 0022-3565Article
Genetic predisposition to drug hepatotoxicity: role in hepatitis caused by amineptine, a tricyclic antidepressantLARREY, D; BERSON, A; PESSAYRE, D et al.Hepatology (Baltimore, Md.). 1989, Vol 10, Num 2, pp 168-173, issn 0270-9139Article
The drug methoxsalen, a suicide substrate for cytochrome P-450, decreases the metabolic activation, and prevents the heptatotoxicity, of carbon tetrachloride in miceLABBE, G; DESCATOIRE, V; LETTERON, P et al.Biochemical pharmacology. 1987, Vol 36, Num 6, pp 907-914, issn 0006-2952Article
The interleukin-2 receptor down-regulates the expression of cytochrome P450 in cultured rat hepatocytesTINEL, M; ROBIN, M.-A; PESSAYRE, D et al.Gastroenterology (New York, NY. 1943). 1995, Vol 109, Num 5, pp 1589-1599, issn 0016-5085Article
Genetically determined oxidation polymorphism and drug hepatotoxicity (study of 51 patients)LARREY, D; TINEL, M; HABERSETZER, F et al.Journal of hepatology. 1989, Vol 8, Num 2, pp 158-164, issn 0168-8278Article
Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytesROBIN, M.-A; MARATRAT, M; LOEPER, J et al.Gastroenterology (New York, NY. 1943). 1995, Vol 108, Num 4, pp 1110-1123, issn 0016-5085Article
